[Nitric oxide--an important mediator in sepsis?]

Area of Science:

• Biomedical science
• Pathophysiology
• Pharmacology

Context:

• Septic shock involves hypotension and organ dysfunction.
• Inducible nitric oxide synthase (iNOS) hyperproduction is implicated in sepsis pathophysiology.
• Animal models show iNOS contributes to adverse hemodynamic effects.

Purpose:

• To review the role of nitric oxide (NO) in sepsis.
• To discuss the therapeutic potential of targeting NO in human septic shock.
• To analyze discrepancies between animal and human data regarding NO inhibition.

Summary:

• Animal studies suggest iNOS inhibition improves sepsis outcomes.
• Human studies on NO synthesis inhibitors yielded conflicting results, with one trial halted due to increased mortality.
• Preexisting conditions in septic patients may increase risks associated with NO inhibition.

Impact:

• Highlights the complex role of NO in human septic shock.
• Questions the universal efficacy and safety of iNOS inhibitors in sepsis treatment.
• Emphasizes the need for cautious therapeutic strategies and further research in human sepsis.